drugset / Trial / NCT04645940

Fruquintinib Food Effect and Proton Pump Inhibitor Study

NCT04645940

Phase 1 Completed 14 enrolled Hutchison Medipharma Limited
RandomizedSequentialOpen-labelBasic science

Summary

The purpose of this is to evaluate the effect of food and the effect of a proton pump inhibitor (rabeprazole) on the pharmacokinetics of fruquintinib.

Timeline

Start
2020-09-24
Primary completion
2020-11-18
Completion
2020-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Fruquintinib Small molecule 5 mg Oral
Background Rabeprazole Small molecule 40 mg Oral

Indications

No indication recorded.